
Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.
We're tracking OpenEvidence's market expansion
How OpenEvidence's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
OpenEvidenceYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
OpenEvidence at ASCO 2026
EndedPhysicians vote with their feet. OpenEvidence is the most trusted Medical AI among U.S. physicians.
ActiveNBC News: "Almost two-thirds of physicians in the U.S. actively use OpenEvidence, across 27 million clinical encounters last month." "Dr. Eric Rubin, the editor-in-chief of The New England Journal of Medicine, said the relationship between his journal and OpenEvidence was 'deeply symbiotic and a win for patients.'" "Dr. Paul Sax, an infectious disease specialist at Boston’s Brigham and Women’s Hospital, said OpenEvidence often “borders on miraculous,” with its AI-supported search providing custo ...
ActiveHLTH 2025 showcases AI advancements in healthcare, including real-world evidence integration, agentic radiology, MRI models, and clinical decision support.
AI revenue concentrates on few companies like OpenAI and Anthropic. Startups diversify beyond subscriptions, exploring advertising models for growth.
Corti launches Startup Acceleration Program offering healthcare AI founders up to $5,000 in credits and regulatory support to navigate €600,000 compliance barriers as Symphony model outperforms OpenAI on healthcare benchmarks.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about OpenEvidence's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.